Literature DB >> 9588854

Supplemental therapy in isolated vitamin E deficiency improves the peripheral neuropathy and prevents the progression of ataxia.

F Martinello1, P Fardin, M Ottina, G L Ricchieri, M Koenig, L Cavalier, C P Trevisan.   

Abstract

A 24-year-old male, who suffered since childhood from a progressive form of ataxia associated with peripheral neuropathy, was found severely deficient in serum vitamin E. He walked with bilateral aid and presented severe dysmetria of the limbs and dysarthric speech; muscular strength and trophism were slightly diminished in the distal muscles of four limbs and there was hypotonia of the arms; he presented absent deep tendon reflexes, bilateral Babinski's sign, reduced proprioception at four limbs, pes cavus and fasciculations of the tongue. Intestinal fat malabsorption and other gastrointestinal or haematological conditions associated with deficiency of this vitamin were ruled out. In this patient, after 2 years of a daily supplement of high doses of vitamin E, a further progression of the disease was not observed and, moreover, the neurophysiological characteristics of his neuropathy appeared clearly improved. A longitudinal evaluation of serum vitamin E levels showed values in the normal range after 13 months of therapy. The patient had molecular genetic analysis of chromosome 8 and was found homozygous for the unusual mutation 513insTT in the alpha-tocopherol transfer protein gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588854     DOI: 10.1016/s0022-510x(98)00038-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  [Clinical details and genetics of recessive ataxias].

Authors:  C Zühlke; F Kreuz; K Bürk
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Ataxia with vitamin E deficiency: update of molecular diagnosis.

Authors:  I Di Donato; S Bianchi; A Federico
Journal:  Neurol Sci       Date:  2010-05-13       Impact factor: 3.307

Review 3.  Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease.

Authors:  Francesco Galli; Mario Bonomini; Desirée Bartolini; Linda Zatini; Gianpaolo Reboldi; Giada Marcantonini; Giorgio Gentile; Vittorio Sirolli; Natalia Di Pietro
Journal:  Antioxidants (Basel)       Date:  2022-05-18

Review 4.  Peripheral neuropathy and inborn errors of metabolism in adults.

Authors:  F Sedel; C Barnerias; O Dubourg; I Desguerres; O Lyon-Caen; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

5.  Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management.

Authors:  M Anheim; M Fleury; B Monga; V Laugel; D Chaigne; G Rodier; E Ginglinger; C Boulay; S Courtois; N Drouot; M Fritsch; J P Delaunoy; D Stoppa-Lyonnet; C Tranchant; M Koenig
Journal:  Neurogenetics       Date:  2009-05-14       Impact factor: 2.660

6.  Ataxia with vitamin e deficiency in norway.

Authors:  Areej Elkamil; Krisztina K Johansen; Jan Aasly
Journal:  J Mov Disord       Date:  2015-01-13

7.  Movement Disorders in Inherited Metabolic Diseases in Children.

Authors:  Arushi Gahlot Saini; Suvasini Sharma
Journal:  Ann Indian Acad Neurol       Date:  2020-05-09       Impact factor: 1.383

8.  Single-Cell RNA-seq Reveals Profound Alterations in Mechanosensitive Dorsal Root Ganglion Neurons with Vitamin E Deficiency.

Authors:  Carrie J Finno; Janel Peterson; Mincheol Kang; Seojin Park; Matthew H Bordbari; Blythe Durbin-Johnson; Matthew Settles; Maria C Perez-Flores; Jeong H Lee; Ebenezer N Yamoah
Journal:  iScience       Date:  2019-10-31

9.  Neurological features and enzyme therapy in patients with endocrine and exocrine pancreas dysfunction due to CEL mutations.

Authors:  Mette Vesterhus; Helge Raeder; Harald Aurlien; Clara G Gjesdal; Cecilie Bredrup; Pål I Holm; Anders Molven; Laurence Bindoff; Arnold Berstad; Pål R Njølstad
Journal:  Diabetes Care       Date:  2008-06-10       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.